.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

BETAXON Drug Profile

« Back to Dashboard
Betaxon is a drug marketed by Alcon Pharms Ltd and is included in one NDA.

The generic ingredient in BETAXON is levobetaxolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levobetaxolol hydrochloride profile page.

Summary for Tradename: BETAXON

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: BETAXON

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 2000DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BETAXON

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 20004,911,920*PED<disabled>
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 20005,540,918*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc